MMEA
VCYT icon

Main Management ETF Advisors’s Veracyte VCYT Stock Holding History

Main Management ETF Advisors’s Portfolio VCYT Stock Details VCYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.72M Buy
63,329
+1,560
+3% +$65.4K 0.11% 38
2026
Q1 		$1.99M Buy
+61,769
New +$2.29M 0.07% 55

Other funds holding VCYT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Main Management ETF Advisors's VCYT Position: Q2 2026 in Review

Main Management ETF Advisors increased its Veracyte (VCYT) stake by 2.5% in Q2 2026, buying an estimated $65.4K and bringing the position to 63,329 shares worth $3.72M. The position accounts for 0.11% of the portfolio, ranked #38.

Main Management ETF Advisors first reported a position in VCYT in Q1 2026 and has held it in 2 quarters since. 370 funds tracked by Wall St. Rank hold VCYT as of Q2 2026.

  • Main Management ETF Advisors held 63,329 shares of Veracyte worth $3.72M as of Q2 2026.
  • Main Management ETF Advisors bought 1,560 Veracyte shares in Q2 2026, an estimated $65.4K.
  • Veracyte made up 0.11% of Main Management ETF Advisors's portfolio in Q2 2026, its #38 holding.
  • Main Management ETF Advisors first reported a position in Veracyte in Q1 2026 and has held it in 2 quarters since.
  • 370 funds tracked by Wall St. Rank held Veracyte as of Q2 2026.

Based on Main Management ETF Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.